At a glance
ClinicalIndex Comparison RecordN/ACompleted· 29 enrolled
Drug / intervention
Radiesse (+) Injectable Implantdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the Merz Jawline Grading Scale (MJGS) Following Radiesse (+)® Correction of Subcutaneous Volume Loss and Contour Deficits of the Jawline - a Canadian Pilot Study
In Brief
A clinical study evaluating Radiesse (+) Injectable Implant for Volume Loss of the Jawline. Completed, enrolled 29 participants.
Detailed Summary
This study will evaluate the sensitivity of the validated Merz Jawline Grading Scale (MJGS) to detect treatment effects following Radiesse (+) correction of subcutaneous volume loss and contour deficits of the jawline. Treatment effects detected on the MJGS will be correlated with assessments of aesthetic outcomes on the Global Aesthetic Improvement Scale (GAIS) and FACE-Q instrument
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVolume Loss of the Jawline
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartJan 2016
Primary CompletionJun 2016
First PostedSep 2016
TodayJul 2026
First PostedSep 16, 2016
Enrollment StartJan 1, 2016
Primary CompletionJun 1, 2016
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 9.8 years ago
Interventions
Radiesse (+) Injectable Implantdevice
Treated subjects will receive a maximum volume of 3.0 cc of Radiesse (+) per jawline.